ABBV-368
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-368, covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]